Price alert —
Sign in to get a one-time email the moment SOLV crosses your price. Free accounts included.
Sign in / create a free accountSolventum Corporation is a healthcare company listed in the US.
SOLV last traded at $81.31, down 0.5% on the day; that's in the upper part of its 52-week range ($62.38–$83.42). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 62), the trend is quiet (ADX 17), and volume is about normal (0.9×). On the business side, revenue is shrinking 3% year over year and the business keeps about 5 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $-3.43 (fair range $-3–$147). The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 54% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.51 (fragile)
- ⚠ Inventory growing faster than revenue
Price implies ~23% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
SOLV is a $13.6 billion company, priced at 10× last year's earnings, and the stock is trading near the top of its 52-week range.